Clinical trial
A Phase III Randomised Study Comparing Concomitant Radiochemotherapy With Cisplatin and Docetaxel as Induction Versus Consolidation Treatment in Patients With Locally Advanced Unresectable Non-small Cell Lung Cancer.
NCT00633568 is registered in ClinicalTrials.gov with European Lung Cancer Working Party as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase III Randomised Study Comparing Concomitant Radiochemotherapy With Cisplatin and Docetaxel as Induction Versus Consolidation Treatment in Patients With Locally Advanced Unresectable Non-small Cell Lung Cancer.
- Lead sponsor
- European Lung Cancer Working Party
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- January 31, 2007
- Completion date
- February 28, 2015
- Enrollment
- 125 (actual)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.
non-small cell lung carcinoma